Sign In
Buy PEN
$319.37
+0.630 (+0.198%)
At Close: Jun 03, 2026
3 Reasons Growth Investors Will Love Penumbra (PEN)
01:46pm, Thursday, 21'st Nov 2024
Penumbra (PEN) possesses solid growth attributes, which could help it handily outperform the market.
Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
04:30pm, Wednesday, 20'th Nov 2024
ALAMEDA, Calif. , Nov. 20, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 36th Annual Healthcare Conference on W
Here is Why Growth Investors Should Buy Penumbra (PEN) Now
01:46pm, Tuesday, 05'th Nov 2024
Penumbra (PEN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why Penumbra (PEN) is a Strong Momentum Stock
10:51am, Tuesday, 05'th Nov 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Data presented for the first time this week at Vascular Interventional Advances (VIVA) 2024 Conference Findings reinforce the clinical, health economic and cost benefits of computer assisted vacuum th
Penumbra Q3 Earnings Beat, Margins Expand, Stock Up in After Market
09:50am, Thursday, 31'st Oct 2024
The third-quarter results reflect another strong performance by Penumbra's U.S. thrombectomy business.
Penumbra, Inc. (PEN) Q3 2024 Earnings Call Transcript
11:45pm, Wednesday, 30'th Oct 2024
Penumbra, Inc. (NYSE:PEN ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Cecilia Furlong - Director of Business Development and Investor Relations Adam Elsesser - C
Penumbra (PEN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
07:36pm, Wednesday, 30'th Oct 2024
While the top- and bottom-line numbers for Penumbra (PEN) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compa
Penumbra (PEN) Q3 Earnings and Revenues Top Estimates
06:31pm, Wednesday, 30'th Oct 2024
Penumbra (PEN) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.67 per share a year ago.
Penumbra, Inc. Reports Third Quarter 2024 Financial Results
04:05pm, Wednesday, 30'th Oct 2024
ALAMEDA, Calif. , Oct. 30, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the third quarter ended September 30, 2024.
Penumbra (PEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Wednesday, 23'rd Oct 2024
Penumbra (PEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Penumbra Stock Zoomed 4% Higher Today
06:20pm, Monday, 14'th Oct 2024
The latest news from the lab, plus an analyst's bullish move, combined to put some zip in the company's shares.
Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke
09:00am, Monday, 14'th Oct 2024
ALAMEDA, Calif. , Oct. 14, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the completion of enrollment in its THUNDER clinical study for patients
Here's Why You Should Retain Penumbra Stock in Your Portfolio Now
09:48am, Wednesday, 09'th Oct 2024
Investors feel optimistic about PEN's strong growth prospects in the Thrombectomy business. Yet, unfavorable forex impacts are concerning.
Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024
04:30pm, Wednesday, 02'nd Oct 2024
ALAMEDA, Calif. , Oct. 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2024 after market close
